Operating Expenses Endring Dato
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
Almirall EUR 427.18M 375K 2023-06
Amarin USD 87.51M 16.62M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Artemis Alpha GBP 748K 85K 2022-06
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Demant DKK 9.14B 552M 2023-06
Exelixis USD 489.5M 97.5M 2023-09
Galapagos EUR 166.58M 9.54M 2023-09
Genmab DKK 3.03B 326M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
GN Store Nord DKK 4.05B 111M 2023-09
GRIFOLS EUR 1.51B 167.87M 2023-12
Hikma Pharmaceutical USD 1.18B 60M 2023-06
Insmed USD 261.96M 35.22M 2023-12
Lonza CHF 2.54B 193M 2023-06
Merck EUR 4.19B 143M 2023-09
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
UCB EUR 2.11B 388M 2023-06



Genmab Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.